• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

christopher.rowe@florey.edu.au

Credentials


Position
Director, Adnet
Florey Department of Neuroscience and Mental Health
Education
Doctorate
University of Melbourne
Bachelors Degree
Flinders University of South Australia
ORCID

0000-0003-3910-2453

Prof Christopher Rowe

Director, Adnet
Florey Department of Neuroscience and Mental Health

1264 Scholarly works
26 Projects

HIGHLIGHTS

  • 2024

    Journal article

    3T sodium-MRI as predictor of neurocognition in nondemented older adults: A cross sectional study
    DOI: 10.1093/braincomms/fcae307
  • 2024

    Research grants (ARC, NHMRC, MRFF)

    Imaging and Blood Biomarkers in a New Era for Alzheimer's Disease Treatment
  • 2021

    Research grants (ARC, NHMRC, MRFF)

    Blood Testing to Predict and Discriminate Dementias
  • 2018

    Research Grant

    The Australian Dementia Network (Adnet): Bringing Together Australia’s Dementia Stakeholders
  • 2016

    Journal article

    Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease
    DOI: 10.1016/j.jalz.2015.12.013
  • 2015

    Journal article

    Phenomenological characterization of memory complaints in preclinical and prodromal alzheimer's disease
    DOI: 10.1037/neu0000156
  • 2013

    Journal article

    Prediction of amyloid-β pathology in amnestic mild cognitive impairment with neuropsychological tests
    DOI: 10.3233/JAD-2012-121315
Christopher Rowe

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Toxoplasma gondii infection is associated with changes in chronic outcomes in traumatic brain injury
    DOI: 10.1038/s41398-026-04150-y
  • 2026

    Journal article

    Redesigning Access: Implementation and Evaluation of a Drop-In Clinic for Telehealth Opioid Use Disorder Treatment.
    DOI: 10.1177/29767342261481495
  • 2026

    Journal article

    Exploring the relationship between methylation of the cortisol receptor genes and brain and cognitive outcomes in individuals with elevated amyloid-β
    DOI: 10.1038/s41398-026-04310-0
  • 2026

    Journal article

    Peripheral DNA methylation of candidate Alzheimer’s disease risk genes and its associations with cognition, brain volume and amyloid-β burden
    DOI: 10.1038/s41598-026-64935-5
  • 2026

    Journal article

    Predicting accumulation and age at onset of amyloid-β from genetic risk and resilience for Alzheimer's disease
    DOI: 10.1016/j.ebiom.2026.106329
  • 2026

    Journal article

    Visual read performance of 18F-Florbetapir and 18F-NAV4694 Aβ PET compared against Centiloid reference standard in a paired cohort
    DOI: 10.1002/dad2.70426
  • 2026

    Journal article

    Breaking Barriers in Early Alzheimer’s Disease Diagnosis: The Power of the In Vitro Diagnostic Elecsys pT181p Immunoassay in a Population Reflective of Real-world Clinical Practice (P4-12.010)
    DOI: 10.1212/wnl.0000000000215575
  • 2026

    Journal article

    Tau positron emission tomography analysis methods for the quantification of tau spread in preclinical and early Alzheimer's disease
    DOI: 10.1002/alz.71573

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224